Get the Stockscreener App
1.43
4.38%
0.06
After Hours:
1.45
0.02
+1.40%
Opko Health Inc stock is traded at $1.43, with a volume of 2.97M.
It is up +4.38% in the last 24 hours and down -20.56% over the past month.
See More
Previous Close:
$1.37
Open:
$1.4
24h Volume:
2.97M
Relative Volume:
0.72
Market Cap:
$1.13B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-7.5263
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
-0.69%
1M Performance:
-20.56%
6M Performance:
-2.05%
1Y Performance:
+16.26%
1-Day Range:
$1.38
$1.45
1-Week Range:
$1.37
$1.45
52-Week Range:
$1.15
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.43 | 1.13B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
434.73 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
192.07 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
421.59 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.81 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.61 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Altshuler Shaham Ltd Buys New Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a Turnaround - Yahoo Finance
OPKO Health Target of Unusually Large Options Trading (NASDAQ:OPK) - MarketBeat
Norges Bank Acquires Shares of 1,127,468 OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Bone Cancer Drugs Market Deep Research 2025-2032 | Advaxis, Inc., Cellectar Biosciences, Inc., OPKO Health, Inc. - openPR.com
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025 - GlobeNewswire
OPKO Health, Inc. (NASDAQ:OPK) boasts of bullish insider sentiment with 52% ownership and they have been buying lately - Yahoo Finance
Q3 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 125,000 Shares - MarketBeat
OPKO Health (NASDAQ:OPK) Earns "Buy" Rating from HC Wainwright - MarketBeat
Quote - OPKO Health, Inc.
NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program - MarketScreener
Opko Health’s CEO Phillip Frost buys $169,712 in stock - Investing.com Australia
Hypopituitarism Market on Track for Major Expansion by 2032, - openPR.com
Hypopituitarism Market on Track for Major Expansion by 2032, According to DelveInsight | OPKO Health, Lumos Pharma, Versartis Inc., I-Mab Biopharma Co. Ltd - The Globe and Mail
Opko Health's CEO Phillip Frost buys $169,712 in stock By Investing.com - Investing.com Canada
Opko Health’s CEO Phillip Frost buys $169,712 in stock By Investing.com - Investing.com South Africa
Opko Health's CEO Phillip Frost buys $169,712 in stock - Investing.com
Weekly Top Insider Buys Highlight for the Week of April 12 - GuruFocus
Opko health CEO Phillip Frost buys $184,650 in stock By Investing.com - Investing.com India
Opko health CEO Phillip Frost buys $184,650 in stock - Investing.com
H.C. Wainwright maintains $3 target, Buy on Opko Health stock By Investing.com - Investing.com UK
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
OPKO Health authorizes $100 million increase to share buyback program - MSN
OPKO Health Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading Volume After Insider Buying Activity - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Sees Large Increase in Short Interest - MarketBeat
Phillip Md Et Al Frost Buys 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
Iron Mountain, EOG, Oklo, NuScale, Opko: Insider Moves Unveiled - TipRanks
OPKO Health Boosts Stock Buyback Program by $100 Million - marketscreener.com
Opko Health Announces $100 Million Increase To Its Existing Share Repurchase Program - MarketScreener
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewswire
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Global Clinical Laboratory Tests Market Set to Witness - openPR.com
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):